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Abstract:  Noma is a serious orofacial gangrene originating intraorally in the gingival-oral mucosa complex before 
spreading extraorally to produce a visibly destructive ulcer. Although cases of noma are now rarely reported in the devel-
oped countries, it is still prevalent among children in third world countries, notably in sub-Sahara Africa, where poverty, 
ignorance, malnutrition, and preventable childhood infections are still common. This review summarizes historical, epi-
demiological, management, and research updates on noma with suggestions for its prevention and ultimate global eradica-
tion. The global annual incidence remains high at about 140,000 cases, with a mortality rate exceeding 90% for untreated 
diseases. Where the patients survive, noma defects result in unsightly facial disfigurement, intense scarring, trismus, oral 
incompetence, and social alienation. Although the etiology has long been held to be infectious, a definitive causal role be-
tween microorganisms cited, and noma has been difficult to establish. The management of noma with active disease re-
quires antibiotics followed by reconstructive surgery. Current research efforts are focused towards a comprehensive un-
derstanding of the epidemiology, and further elucidation of the microbiology and pathogenesis of noma. 
Although a formidable public health challenge, noma can be prevented with a potential for subsequent global eradication. 
To achieve both desirable goals, detection of early disease is crucial because these early lesions respond to conventional 
antibiotic treatments when instituted side by side with nutritional rehabilitation, and obviates the necessity for extensive 
surgical reconstruction often indicated in late stage disease. The eradication of noma in the developed world in the mid 
20
th century bears out the notion of a similar outcome following effective preventive strategies in Africa. A fundamental 
and necessary step towards attaining this goal is for the international community to adopt a perception of noma as an ur-
gent global public health challenge. Research effort toward deciphering the microbiology, molecular events, and patho-
genesis of noma also should intensify.  
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BACKGROUND 
Noma (cancrum oris) is a debilitating gangrenous disease 
of the orofacial region. It occurs in several regions of the 
world, including the United States but with notable preva-
lence in sub-Sahara Africa [1, 2].
 Although noma can affect 
patients of any age group, infants and children are particu-
larly susceptible [1].
 Against a background of poor oral hy-
giene, long established common denominators to all noma 
patients are malnutrition, depressed immunity, and increased 
susceptibility to infections with normal oral commensal bac-
teria [3-7].
 However, it is also true that not all patients, even 
with the complete set of predisposing conditions, develop 
noma. Indeed, because the majority of patients with these 
backgrounds never develop noma, it is reasonable to postu-
late that the biological factors enumerated above may only 
complement a stage set by other preexisting genetic and en-
vironmental conditions for the pathogenesis of noma.  
Noma continues to be a significant cause of death among 
child patients in areas where it is currently endemic [3].
 In 
the absence of timely therapeutic intervention, the mortality 
rate is estimated at about 70-90% [8, 9]. When not fatal, 
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noma leads to severe destruction of the mid-face structures, 
notably the lips, cheek, maxilla, mandible, nose, and orbital 
floor [3, 7, 9]. With the disfiguring sequel comes impaired 
self-nutrition, speech, and ultimately, social rejection [10]. 
Antibiotic regimens remain the mainstay of treatment for 
active disease. Plastic and reconstructive surgical procedures 
are subsequently employed for the repair of the substantial 
orofacial hard and soft tissue defects resulting from a com-
pleted natural course of the disease [10-12].
  
Africa not only maintains a disproportionate burden of 
noma cases currently, but this avoidable and preventable 
condition remains a visible scourge of African children [4, 
13]. This review recaptures salient historical aspects of 
noma, and summarizes management and research updates on 
the etiology and pathogenesis of the disease. Strategies nec-
essary for the prevention and ultimate eradication of noma 
are proffered. 
 
DISCUSSION 
Historic and Epidemiological Profile of Noma 
The word “noma” is a derivative of the Greek word 
“nomein”, which means, “to devour”; an obvious allusion to 
the rapidly destructive characteristic of the gangrene [2, 14]. 
The first clinical description of the disease was said to be in 
1595 by Carolus Battus, a Netherlands surgeon [15]. Subse-202    The Open Dentistry Journal, 2010, Volume 4  Ogbureke and Ogbureke 
quently, A.L. Richter (a Berlin physician) in 1828 drew at-
tention to the presence of noma throughout Europe over 
many centuries [16]. In his book, Richter also associated the 
disease with malnutrition and childhood infections such as 
measles. By the end of the 19
th century, noma had virtually 
disappeared from Western Europe as a result of improved 
nutrition and hygiene among poor people [10, 17]. Although 
during the Second World War cases of noma were rife in 
Nazi concentration camps where victims died as a result of 
malnutrition [18, 19] treatment of active noma became pos-
sible with the discovery of penicillin but paradoxically after 
the disappearance of the disease from Europe.  
Noma still remains the true “face of poverty” in less de-
veloped (and therefore impoverished) nations [20]. The 1994 
report of the World Health Organization (WHO) character-
ized noma as a global health priority in response to reports 
from humanitarian organization indicating increases in the 
incidence of noma in various African countries [2, 21-24]. 
The report also coincided with an escalating economic crisis 
within the continent, combined with the advent of 
HIV/AIDS and the AIDS epidemic that followed, and an 
increasing number of armed conflicts. These conditions bear 
directly on the health and well being of children through 
overcrowded living conditions, deteriorating sanitation, and 
inadequate nutrition. In accord with its 1994 report, the 
WHO established a global campaign against noma as one of 
the initiatives emerging from that year’s WHO Day celebra-
tion. It also initiated an action program by way of a joint 
project with the United States National Institute of Health 
(NIH) and the University of Maryland Baltimore, Maryland 
[2]. It stands to reason therefore that noma falls within the 
rubric of neglected infectious diseases within the domain of 
the dentist’s practice. 
Although epidemiological facts and figures relating to 
noma are at best fragmented and speculative, recent evidence 
points to an increasing incidence of noma, particularly in the 
poorer regions of Africa [4, 25, 26]. In 1998, the WHO made 
available the first estimates on the incidence and prevalence 
of noma with a worldwide annual incidence of 140,000 
cases, and a prevalence of 770,000 in 1997 [9]. Estimates put 
the world number of children under the age of six years with 
noma in the order of several hundred thousand per year, in-
cluding about 100,000 African children per year [3, 27]. The 
estimated incidence is between one and seven cases per 1000 
population in African countries, and up to 12 cases per 1000 
in the most affected communities [8, 13].  
The main obstacle to the procurement of concrete global 
epidemiological data on noma is the limited or non-access of 
patients to healthcare centers and the attendant inadequacies 
of health record-keeping [8]. In addition, family members of 
patients as well as health personnel are often incapable of 
recognizing the condition. It is also not uncommon for noma 
to evolve so rapidly that death ensues before the patients can 
avail themselves of assistance from health facilities. 
Etiologic and Risk Factors for Noma 
Socioeconomic  Factors. Poverty remains the single 
most important risk indicator for noma [13]. Other related 
factors include chronic malnutrition, poor environmental 
sanitation, unsafe water supply, close residential proximity 
to livestock, and increased exposure to viral and bacterial 
agents [3, 28]. As of 1999, sub-Sahara Africa harboured 38 
of the world’s 63 low-income nations, with a per capita an-
nual income of $700, and with 40% of its 500 million people 
subsisting on less than $1.00 per day [4, 29]. Thus, interplay 
of economic globalization with confounders such as war and 
drought constitutes the composite etiologic factor for noma 
[30, 31]. 
The global distribution pattern of noma mirrors the 
worldwide distribution of malnutrition, particularly that due 
to vitamin A deficiency in children under the age of 5 years 
[8, 32]; an observation that recapitulates that at the Nazi con-
centration camps where noma was rife in the 20
th century. In 
Nigeria, for example, most cases of noma become evident 
during the “dry season”, an annual climatic variation coin-
ciding with the “hungry months” due to food shortage [28, 
29, 33, 34]. The hungry months in Nigeria also coincide with 
the period of highest incidence of annual measles outbreaks 
[28, 29, 35, 36]. Anthropometric, biochemical, and clinical 
assessments of rural children in Sokoto Nigeria by Enwonwu 
et al. [3] showed widespread severe protein energy malnutri-
tion (PEM) among noma patients when compared to their 
healthy but at-risk age-matched ethnic counterparts. The 
Sokoto village children studied by Enwonwu et al. [3] also 
exhibited marked deficiencies of retinol, ascorbate, zinc, and 
the essential amino acids.  
Antecedent Oral and Systemic Conditions. Poor oral hy-
giene is a significant risk factor and follows as a natural se-
quel of ignorance and poverty rife in these communities [13, 
34].
 Poor oral hygiene is an essential predisposing condition 
to necrotizing ulcerative gingivitis (NUG) [13, 37]. NUG, 
generally considered a key predisposing factor (and not in-
frequently alluded to as a precursor lesion) to noma, is a so-
cioeconomic disease that was seen almost exclusively among 
children in the developing countries following the end of the 
Second World War [25, 37, 38]. Clinically, NUG presents as 
a recurring gingival infection of complex etiology, character-
ized by necrosis of the interdental papillae, spontaneous 
bleeding, and pain (Fig. 1). Like noma, the pathogenesis of 
NUG is poorly understood although causative association 
with specific microorganism such as spirochetes, Prevottela 
intermedia, cytomegalovirus, Epstein-Barr, herpes simplex 
 
Fig. (1). Acute necrotizing ulcerative gingivitis (ANUG) showing 
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viruses, and the measles virus is often cited [13, 25, 39-42].
 
Often patients may be under stress, immunosuppressed, or 
have endocrine dysfunction as additional predisposing condi-
tions [3, 38, 43, 44]. 
Consistent with earlier reports [3, 45, 46]
 we have, over 
the years, observed that infection with measles (Fig. 2) most 
commonly antedates the development of noma in African 
children. In this respect other authors have cited interleukin-
12 (IL-12), an essential cytokine for the generation of cell-
mediated immunity, as being down-regulated in measles 
patients [3]. Records of other antecedent infections include 
malaria, tuberculosis, chicken pox, gastroenteritis, and bron-
chopneumonia [3, 47].
 
Microbiology of Noma. Although noma is presumed to be 
of infectious aetiology, elucidating the precise microbiolog-
ical culprits remains somewhat of an enigma. The primary 
reason for this obscurity is obvious: the epicenter of noma 
development, the oral cavity, is inhabited by several hundred 
species of normal commensal bacteria [48-51]. A long held 
notion is that noma is caused by spirochetes and fusobacteria 
[5, 6, 52]. This notion partly stems from an extrapolation of 
the microbiological culprits of the presumed noma antece-
dent, NUG, which also includes spirochetes and fusobacte-
ria, and partly because the levels of these organisms appear 
to be elevated in noma. However, a search of the English 
literature to date showed no reports of genotypic alterations 
from commensal to pathogenic among this group of organ-
ism in noma lesions. Furthermore, attempts to recapitulate 
the lesions of noma (or NUG) in animal models via inocula-
tion of suspect oral organisms in the absence of predisposing 
conditions such as high plasma cortisol and depressed im-
munity have met with little success [2]. These findings chal-
lenge current etiologic concepts and continue to engender 
intense research effort in this direction. As a result, new 
theories are emerging regarding the pathogenesis of noma 
[53].  
Another difficulty encountered results from a common 
speculation that differences in microbial population might 
exist between “early” and “advanced” lesions. Parameters 
for “early” and “advanced” noma lesions are yet to be pre-
cisely defined. In a broad sense however the early lesion 
refers to the reddish/purple-coloured indurations (Fig. 3) 
assumed to subsequently extend via ulceration and necrosis 
to adjoining hard and soft tissues of the orofacial region in 
the absence of timely treatment. On the other hand, the con-
cept of advanced lesions alludes to the highly visible facial 
tissue destruction evidenced by the presence of exposed 
and/or sequestrated dead bone and soft tissue necrosis (Fig. 
4) seen at later stages of the disease, or with rapidly pro-
gressing disease. 
Nevertheless, recent reports suggest that noma is caused 
by a mixed infection of oral and extraoral opportunistic 
pathogens [3, 5, 6, 54]
 while incorporating the proposal that 
some noma cases may be the result of zoonotic infection 
with  Fusobacterium  necroforum. Using culture-independent 
molecular methods, Paster et al. [54]
 reported the detection 
of 67 bacterial species or phylotypes in advanced noma le-
sion of four Nigerian patients. Of these, phylotytpes that 
were unique to noma infections included those in the genera 
Eubacterium, Flavobacterium, Kocuria, Microbacterium, 
Porphyromonas, Streptococcus (salivarius), Sphingomonas, 
and Treponema. Twenty five species had not yet been grown 
in vitro, 19 phylotypes, including Propionibacterium acne, 
Staphylococcus species, and the opportunistic pathogens 
Stenotrophomonas maltophilia and Ochrobacterum antrophi 
were found in samples from one of the four patients. The 
authors suggested that the presence in advanced noma le-
sions of organisms not normally associated with the oral 
cavity may be due to contamination from the extraoral envi-
ronment [54]. It however remains to be seen whether the 
microbial constituent of “early” lesions differs remarkably 
from that of advanced lesions.  
Current Management Approaches 
The consequences of noma relate to functional and es-
thetic problems. The acute and fulminating early stages of 
the disease indicate need for antibiotic treatment, while the 
chronic and disfiguring late stage requires surgical interven-
tion: plastic and reconstructive surgeries designed to suit 
individual cases.  
Medical Management: During the acute stage, treatment 
strategies aim to improve the overall health status of patients. 
This includes nutritional, correction of ionic and acid-base 
imbalances, administration of vitamins, and the administra-
tion of broad spectrum antibiotics to control infection [2]. In 
our cumulative experiences spanning over two decades at 
both the Maxillofacial Unit of the Ahmadu-Bello University 
Hospital, Kaduna (KUEO) and the Noma Children Hospital 
 
Fig. (2). Patients with measles (A and B). Measles (B; arrow) usu-
ally antedate ANUG. (B; arrow). 
 
Fig. (3). Necrotic (Arrow ) erythematous ulcer still confined to the 
alveolus and gingiva. This may represent the so-called “early 
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Sokoto, Nigeria, antibiotics of the penicillin group with es-
tablished potency in bone infections in combination with 
metronidazole were found to be consistently useful in arrest-
ing the fulminating acute phase of noma. Overall, the “gold-
standard” remains that antibiotics administered at the acute 
phase must be sufficiently broad to cover the spectrum of 
aerobic and anaerobic organisms inhabiting the periodontium 
and oropharynx [2]. Improved oral hygiene instructions and 
strategy also must accompany early phase treatment. 
Surgical Reconstruction: In the African settings where 
noma is overwhelmingly prevalent, there is also a shortage 
of qualified surgical teams to treat the number of patients 
requiring reconstruction [2, 25].
  In some of these centers, 
such as the Noma Children’s Hospital in Sokoto, Nigeria, the 
local teams of surgeons and nurses are periodically supple-
mented by a volunteer team of expert representatives of hu-
manitarian projects based in the developed countries [55].  
The timing of surgical intervention in the management of 
noma is critical. All forms of invasive surgery in the vicinity 
of an acute phase lesion are discouraged because of the po-
tential for such intervention to accelerate the destructive evo-
lution of the disease. However, as soon as the acute phase is 
visibly contained, usually evidenced by clear fibrotic demar-
cation at the normal tissue-lesion interface (see Fig. 4) the 
design of surgical reconstruction should commence. Simul-
taneously, pre-surgical oral physiotherapy to relieve the 
trismus resulting from the fibrous strictures and ankylosis 
thereby enhancing intraoral access during surgery should 
also commence. In Nigerian centers, for example, graduated 
acrylic mouth screws are designed and fabricated, and these 
are employed to relieve trismus and enhance mouth opening. 
Physiotherapy continues postsurgical until acceptable or 
normal mouth opening is achieved. 
Over the years, the surgical corrections of noma deformi-
ties have proved to be daunting because each new case ap-
pears to present a unique composite of reconstructive chal-
lenges. There is therefore no standard surgical approach 
common to all noma cases. Nevertheless, certain ground 
rules for surgical treatment of noma appears to exist, and 
include the postponement of treatment of lesions less than 
one-year-old (except where the sequelae created an urgent 
indication to improve nutritional intake), and the debride-
ment of the lesion to avoid secondary infection [2]. Routine 
presurgical clinical investigations, including full blood count 
and differentials, chest, skull and, when feasible, full mouth 
radiological examinations must be carried out and docu-
mented. Skull radiographs that usually include temporoman-
dibular joint (TMJ) views reveal the extent of bony ankylosis 
and trismus present in a particular patient [11, 56-58]. Vari-
ous profiles of presurgical photographs are also documented, 
and subsequently used side-by-side with postsurgical photo-
graphs and other clinical parameters to assess treatment out-
come. 
Surgery, which is invariably under general anesthesia, 
sometimes presents peculiar anesthetic technique challenges 
and risks. For example, because most noma patients with 
significant loss of orofacial tissues and scarring develop lim-
ited mouth opening, intubation for general anesthesia is 
sometimes challenging. Before the advent of fibreoptic tech-
nology [59], intubation for anesthesia of noma patients pre-
paratory for surgery presented significant risks and chal-
lenges, often compounded by the shortage of experienced 
nursing staff at centers located in the noma “hot spots” in 
Africa. It was therefore not uncommon for patients who elec-
tively present for the repair of their defects for social rea-
sons, to die from anaesthetic complications during or after 
surgery.  
Generally, the surgical designs involve the raising and 
transposition of local and distant soft tissue flaps, depending 
on the extent of tissue loss (see Fig. 4). In cases of consider-
able loss of facial or jaw bone, bone grafting may be consid-
ered in the sequence of reconstructive design. While a dis-
cussion of the technical details for each of the reconstructive 
designs advocated by various practitioners, together with 
their philosophies, is beyond the scope of this review, refer-
ences to these details are cited in the text. Nevertheless, the 
three fundamental principles underlying every good surgical 
reconstruction design for noma repair are summarized. First, 
due to the substantial tissue loss characteristics of most noma 
defects, designs must account for adequate vascular supply 
capable of sustaining flap viability [54, 60]. Therefore, both 
locoregional and pedicled flaps must maintain adequate dis-
tance from pathological tissues. Second, designs must aim 
for optimal length pedicles capable of anastomoses with lo-
cal vessels in the area of repair [54, 59]. Third, an inner lin-
ing of the flap is required to prevent re-scarring and conse-
quent functional impairment [61]. The deltopectoral, pedi-
cled latissimus dorsi, pedicled radial forearm, and various 
designs of forehead flaps are routinely employed to close 
noma defects and provide outer lining [55]. Split-thickness 
skin grafts are commonly used to provide inner linings. 
The deltopectoral flap has been used as both outer and 
inner linings with satisfactory results, and remains the most 
versatile flap for the reconstruction of facial defects [57, 62, 
63]. The advantage of the deltopectoral flap lies in the rela-
tive simplicity of its design, minimal blood loss during sur-
gery, and the viability of the flap after surgery [62, 63]. The 
various forehead flap designs are also simple. However, a 
main criticism of the forehead flaps is that they often result 
in unsightly appearance of the donor site.  
 
Fig. (4). Advanced noma lesions. A. Rapidly destructive and fulmi-
nating disease requiring lengthy antibiotic treatment prior to sur-
gery. B. Arrested advanced disease requiring short course of antibi-
otics before surgical reconstruction (arrow indicates sequestrum 
formation (4A is adapted from Noma Project, Courtesy of Noma 
Children Hospital, Sokoto, Nigeria). NOMA: A Preventable “Scourge” of African Children  The Open Dentistry Journal, 2010, Volume 4    205 
The various myocutaneous flaps mentioned above are in-
tricate and should be employed only by practitioners with the 
appropriate experience and where adequate postoperative 
care is available because of the associated longer morbidity. 
Nath and Jovic [62, 63] advocate that myocutaneous flaps be 
sparingly used, if at all, in children. However, it would ap-
pear that for some considerably large and sophisticated de-
fects myocutaneous flaps would remain the only viable re-
constructive option. The Abbe-Estlander, nasolabial, and 
temporoauricular (Washio type) are local flaps that produce 
excellent results in small to moderate defects involving the 
upper lip, paranasal, and nasal areas [61]. Closure of orona-
sal fistulas can be achieved with the aid of tongue flaps [11]. 
Overall, because of the complexity of most noma defects, 
single surgical procedures are not always feasible, and most 
cases require revision surgeries to correct residual undesired 
functional and esthetic outcome of initial treatment.  
Research Update 
Prior to designating noma as one of the five global priori-
ties for study by a joint initiative between NIH/NIDCR and 
WHO/ORH in the early 1990s, studies were carried out with 
less coordination amongst groups in the forefront of noma 
research. Following the characterization of noma as a major 
health problem requiring integrated international resources 
and expertise, the Federation Dentaire International (FDI) 
and the WHO Joint Working Group in 1992 launched the 
International Action Network Against Noma in 1994 [4]. 
This on-going initiative prompted studies that are now more 
coordinated with the ultimate goal of preventing and eradi-
cating noma. It is hoped that this goal will be attained 
through studies elucidating more clearly the epidemiology of 
noma and its etiopathogenesis. In this regard, of course, the 
main battle-ground remains the developing countries of sub-
Sahara Africa.  
A combined team of researchers from the Dental School 
of the University of Maryland, Forsyth Institute Boston, the 
Nigerian Institute of Medical Research Lagos, and the Uni-
versity of Lagos, School of Dentistry has been investigating 
the microbiological etiology of noma, as well as the immune 
and nutritional statutes of noma patients in Sokoto, Nigeria 
over the past decade.  
SUMMARY 
Although a formidable public health challenge, noma is 
both preventable and amenable to eradication. Detection of 
early lesions is crucial to an overall preventative goal be-
cause these early lesions respond to conventional antibiotic 
treatments when instituted side by side with nutritional reha-
bilitation, thereby obviating the late stage and potentially 
lethal gangrenes. The concept of “think globally act locally” 
[31] is clearly germane to the goal of eradicating noma in 
Africa and, by implication, globally. A fundamental and 
necessary step towards attaining this goal is for the interna-
tional community to adopt a perception of noma as an urgent 
global public health challenge. This challenge must then be 
confronted by international agencies and research-sponsoring 
organization by addressing the various local logistical obsta-
cles, increasing financial support for on-going research ac-
tivities, and training local research scientists and mentors for 
noma centers in Africa.  
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